These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37420135)

  • 21. Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-γ agonists as anti-diabetic drugs.
    Ahmed S; Islam N; Shahinozzaman M; Fakayode SO; Afrin N; Halim MA
    J Biomol Struct Dyn; 2021 Feb; 39(2):728-742. PubMed ID: 31916505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study.
    Antony P; Vijayan R
    PLoS One; 2015; 10(9):e0138186. PubMed ID: 26384019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Didymin, a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Ali MY; Zaib S; Rahman MM; Jannat S; Iqbal J; Park SK; Chang MS
    Chem Biol Interact; 2019 May; 305():180-194. PubMed ID: 30928401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of indole-substituted thiosemicarbazones as an aldose reductase inhibitor: an 
    Shehzad MT; Khan A; Halim SA; Hameed A; Imran A; Iqbal J; Ullah A; Asari A; Khan S; Shafiq Z; Al-Harrasi A
    Future Med Chem; 2021 Jul; 13(14):1185-1201. PubMed ID: 34148377
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1
    Mustafa G; Mahrosh HS; Zafar M; Attique SA; Arif R
    Int J Immunopathol Pharmacol; 2022; 36():3946320221103120. PubMed ID: 35574607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant?
    Ballekova J; Soltesova-Prnova M; Majekova M; Stefek M
    Physiol Res; 2017 Sep; 66(4):687-693. PubMed ID: 28406694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
    Kadam A; Dawane B; Pawar M; Shegokar H; Patil K; Meshram R; Gacche R
    Bioorg Chem; 2014 Apr; 53():67-74. PubMed ID: 24607578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
    Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
    BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
    Gopal K; Karwi QG; Tabatabaei Dakhili SA; Wagg CS; Zhang L; Sun Q; Saed CT; Panidarapu S; Perfetti R; Ramasamy R; Ussher JR; Lopaschuk GD
    Cardiovasc Diabetol; 2023 Mar; 22(1):73. PubMed ID: 36978133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
    Singh S; Mohanty A
    J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight into Shenqi Jiangtang Granule on the improved insulin sensitivity by integrating in silico and in vivo approaches.
    Shi S; Sun M; Liu Y; Jiang J; Li F
    J Ethnopharmacol; 2022 Jan; 282():114672. PubMed ID: 34560213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
    Tokalı FS; Demir Y; Türkeş C; Dinçer B; Beydemir Ş
    Drug Dev Res; 2023 Apr; 84(2):275-295. PubMed ID: 36598092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-graphene oxide quantum dots nanoconjugate as dual purpose drug delivery and therapeutic agent in meta-inflammation.
    Sarkar K; Bank S; Chatterjee A; Dutta K; Das A; Chakraborty S; Paul N; Sarkar J; De S; Ghosh S; Acharyya K; Chattopadhyay D; Das M
    J Nanobiotechnology; 2023 Aug; 21(1):246. PubMed ID: 37528408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
    Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
    J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
    Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
    Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.